As the shortage of children’s pain medications continues, four Massachusetts lawmakers questioned Johnson & Johnson, the largest U.S. pharmaceutical company by revenue, about its supply of Tylenol and Motrin in a letter sent Jan. 12.
Read the full post on Becker's Hospital Review - Healthcare News
